Sorafenib plus cisplatin and gemcitabine in the treatment of advanced hepatocellular carcinoma (HCC): A phase II study by the Gruppo Oncologico dell'Italia Meridionale (prot. GOIM 2705). Background: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback